DK3397619T3 - Salve - Google Patents

Salve Download PDF

Info

Publication number
DK3397619T3
DK3397619T3 DK16828990.8T DK16828990T DK3397619T3 DK 3397619 T3 DK3397619 T3 DK 3397619T3 DK 16828990 T DK16828990 T DK 16828990T DK 3397619 T3 DK3397619 T3 DK 3397619T3
Authority
DK
Denmark
Prior art keywords
ointment
Prior art date
Application number
DK16828990.8T
Other languages
English (en)
Inventor
Yoshihiro Murakami
Hitoshi Matsushita
Kengo Matsumoto
Minoru Okada
Yohei Yuki
Noriyuki Koyama
Naohiko Kanai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK3397619T3 publication Critical patent/DK3397619T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK16828990.8T 2015-12-28 2016-12-27 Salve DK3397619T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015256784 2015-12-28
PCT/JP2016/088843 WO2017115780A1 (en) 2015-12-28 2016-12-27 Ointment

Publications (1)

Publication Number Publication Date
DK3397619T3 true DK3397619T3 (da) 2020-08-24

Family

ID=57851287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16828990.8T DK3397619T3 (da) 2015-12-28 2016-12-27 Salve

Country Status (15)

Country Link
US (4) US10588893B2 (da)
EP (1) EP3397619B1 (da)
JP (4) JP6873128B2 (da)
KR (3) KR20240034867A (da)
CN (1) CN108473448A (da)
AU (1) AU2016382036B2 (da)
CA (1) CA3009734C (da)
DK (1) DK3397619T3 (da)
ES (1) ES2811849T3 (da)
MY (1) MY197975A (da)
PH (1) PH12018501346B1 (da)
SA (1) SA518391908B1 (da)
SG (2) SG11201805364TA (da)
TW (1) TWI726027B (da)
WO (1) WO2017115780A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3774745T3 (pl) 2018-04-04 2024-08-19 Otsuka Pharmaceutical Co., Ltd. Kryształ cząsteczki oksazolu
JP7051968B2 (ja) * 2019-10-09 2022-04-11 大塚製薬株式会社 オキサゾール化合物結晶
EP4501324A4 (en) * 2022-03-25 2026-04-08 Otsuka Pharma Co Ltd WOUND TREATMENT COMPOSITION
JP2024123673A (ja) * 2023-03-01 2024-09-12 ダイキン工業株式会社 フッ素原子含有化合物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
TW202612685A (zh) * 2024-05-29 2026-04-01 日商大塚製藥股份有限公司 包含唑化合物之組合物
CN120097978A (zh) * 2024-07-05 2025-06-06 广东省科学院动物研究所 新型pde4抑制剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419963B1 (en) * 2001-04-22 2002-07-16 Sarfaraz K Niazi Composition and method for the treatment of diaper rash using natural products
US7655717B2 (en) * 2002-07-17 2010-02-02 Mary J. Goulbourne Ointment composition for treating decubitus ulcers and methods for its making and its use
TW200418516A (en) * 2003-02-21 2004-10-01 Shionogi & Co Droplet dispersed ointment
TWI330639B (en) * 2005-11-15 2010-09-21 Otsuka Pharma Co Ltd Oxazole compound and pharmaceutical composition
CA2738831C (en) * 2008-10-08 2016-05-24 Takata Seiyaku Co., Ltd. Tacrolimus preparation for external applications
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
EP2890686B1 (en) * 2012-08-30 2017-01-04 Otsuka Pharmaceutical Co., Ltd. Method for producing oxazole compound

Also Published As

Publication number Publication date
CA3009734A1 (en) 2017-07-06
NZ743851A (en) 2021-09-24
JP2019503989A (ja) 2019-02-14
EP3397619A1 (en) 2018-11-07
SG10201912634QA (en) 2020-02-27
TW201729806A (zh) 2017-09-01
JP2025024065A (ja) 2025-02-19
EP3397619B1 (en) 2020-07-29
PH12018501346B1 (en) 2022-01-07
MY197975A (en) 2023-07-25
PH12018501346A1 (en) 2019-02-18
JP6873128B2 (ja) 2021-05-19
ES2811849T3 (es) 2021-03-15
CA3009734C (en) 2025-07-08
AU2016382036A1 (en) 2018-07-12
TWI726027B (zh) 2021-05-01
KR102643824B1 (ko) 2024-03-07
WO2017115780A1 (en) 2017-07-06
US20190000810A1 (en) 2019-01-03
SA518391908B1 (ar) 2022-06-05
US20240366573A1 (en) 2024-11-07
KR20250044948A (ko) 2025-04-01
US10588893B2 (en) 2020-03-17
CN108473448A (zh) 2018-08-31
US20200171006A1 (en) 2020-06-04
KR20240034867A (ko) 2024-03-14
JP2023058571A (ja) 2023-04-25
HK1255187A1 (en) 2019-08-09
US20220117944A1 (en) 2022-04-21
AU2016382036B2 (en) 2021-02-04
SG11201805364TA (en) 2018-07-30
KR20180097672A (ko) 2018-08-31
JP2021107437A (ja) 2021-07-29

Similar Documents

Publication Publication Date Title
NL301301I2 (nl) ciltacabtagene autoleucel
FIC20240004I1 (fi) Pirtobrutinibi
FIC20230006I1 (fi) Vutrisiraani
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3331869T3 (da) Muscarinagonister
DK3265421T3 (da) Doseringssystem
DK3277719T3 (da) Polypeptider
EP3316375A4 (en) Redox flow cell
DK3305788T3 (da) Janus-kinase-hæmmer
EP3290364A4 (en) Conveyor belt wear monitoring system
EP3395868A4 (en) STRUCTURE
DK3310450T3 (da) Olie-vand-separator
EP3345473A4 (en) HARVESTER
DK3270930T3 (da) Præeklampsi
EP3343603A4 (en) STRUCTURE
EP3383912A4 (en) TOPICAL FORMULATIONS
EP3351087A4 (en) HARVESTER
DK3296597T3 (da) Krydshovedmotor
EP3373875A4 (en) BANDAGE
HUE054735T2 (hu) Topikális formuláció
DK3292136T3 (da) Penicillin-g-acylaser
EP3390240A4 (en) LOADING STRUCTURE
DK3274482T3 (da) Stenborsknop
EP3390373C0 (en) DOTA SUMMARY
EP3299263A4 (en) TRACTOR